INTENSITY THERAPEUTICS, INC. (INTS)
Intensity Therapeutics, Inc. operates as biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.
Address
61 WILTON ROAD, 3RD FLOOR
WESTPORT, CT 06880
Founded
2012
Number of Employees
17
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)